Published in N Engl J Med on October 20, 1977
Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A (1991) 1.31
Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun (1988) 1.19
Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. Proc Natl Acad Sci U S A (1992) 1.11
Infection-associated encephalopathies: their investigation, diagnosis, and treatment. J Neurol (2006) 1.03
Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro. Clin Exp Immunol (1988) 0.86
Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis. Clin Exp Immunol (2001) 0.84
Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients. Clin Exp Immunol (1980) 0.84
Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals. Clin Exp Immunol (2002) 0.83
Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease. Immunology (1998) 0.80
Cold reactive antilymphocyte antibodies in neurological diseases. J Neurol Neurosurg Psychiatry (1979) 0.80
Glatiramer acetate and nanny proteins restrict access of the multiple sclerosis autoantigen myelin basic protein to the 26S proteasome. Biomed Res Int (2014) 0.80
Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals. J Clin Invest (1984) 0.78
Immunity to heat shock proteins and neurological disorders of women. Infect Dis Obstet Gynecol (1999) 0.75
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis. Iran J Pathol (2015) 0.75
Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature (1978) 3.29
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy Appl Immunol (1971) 1.68
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest (1995) 1.63
Muscular dystrophy in young girls. Neurology (1970) 1.60
The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med (1974) 1.50
Cell type-specific markers for human glial and neuronal cells in culture. Lab Invest (1980) 1.49
Histamine suppression of human lymphocyte responses to mitogens. Cell Immunol (1978) 1.48
Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood (1976) 1.44
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. Eur J Neurol (2001) 1.41
Chronic urticaria/angioedema and Graves' disease: Coexistence of 2 antireceptor antibody-mediated diseases. J Allergy Clin Immunol (2001) 1.41
Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology (1974) 1.35
Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26
Multiple sclerosis and Sjögren's syndrome: a problem in diagnosis or in definition of two disorders of unknown etiology? Ann Neurol (1990) 1.26
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler (2000) 1.23
Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol (1983) 1.23
Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell Immunol (1987) 1.20
Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med (1977) 1.20
The prognosis of lupus nephritis. Role of clinical-pathologic correlations. Ann Intern Med (1968) 1.19
Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein. J Immunol (1970) 1.19
Effects of azathioprine therapy on bone marrow-dependent and thymus-dependent cells in man. Clin Exp Immunol (1973) 1.17
Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet (1968) 1.17
A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients. Mult Scler (2006) 1.15
Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet (1976) 1.14
Patterns of allergic respiratory disease in children with a past history of bronchiolitis. J Allergy Clin Immunol (1971) 1.14
Hyperkalemic periodic paralysis and cardiac arrhythmia. Neurology (1972) 1.13
An approach to the performance of contrast studies in contrast material-reactive persons. Ann Intern Med (1975) 1.12
Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans. Ann Intern Med (1977) 1.12
Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol (1980) 1.11
Coccidioidin delayed hypersensitivity: skin test and in vitro lymphocyte reactivities. J Immunol (1969) 1.10
Transfer factor deficiency response--a mechanism of anergy in Boeck's sarcoid. Trans Assoc Am Physicians (1968) 1.10
T and B lymphocytes in multiple sclerosis. Clin Exp Immunol (1975) 1.09
In vitro effects of measles virus on proliferating human lymphocytes. J Immunol (1971) 1.09
Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol (1981) 1.09
Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients. Isr J Med Sci (1978) 1.09
Antigen-induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromoglycate. J Allergy Clin Immunol (1978) 1.08
Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol (1980) 1.07
Histologic studies of human skin test responses to ragweed, compound 48-80, and histamine. J Allergy Clin Immunol (1973) 1.07
Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis. Cell Immunol (1974) 1.06
The direct demonstration of histamine release in allergic reactions in the skin using a skin chamber technique. J Allergy Clin Immunol (1978) 1.04
Transient global amnesia due to a dominant hemisphere tumor. Arch Neurol (1977) 1.03
Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions. J Allergy Clin Immunol (1980) 1.02
Mitogens for glial cells: a comparison of the response of cultured astrocytes, oligodendrocytes and Schwann cells. Brain Res (1981) 1.02
In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol (1982) 1.02
Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates. Arch Neurol (1973) 1.00
Azathioprine in the treatment of myasthenia gravis. Ann Neurol (1984) 0.99
Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology (1993) 0.99
Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration. Arch Neurol (1975) 0.98
Multiple sclerosis: evidence for immunopathogenesis. Neurology (1980) 0.98
Search for anti-encephalitogen antibody in human demyelinative diseases. Neurology (1968) 0.98
Temporal relationship between tuberculin skin reactivity and in vitro mitotic response. Immunology (1967) 0.97
Long term culture of bovine oligodendroglia isolated with a Percoll gradient. Brain Res (1981) 0.97
Immunopathogenesis and treatment of myasthenia gravis. J Clin Immunol (1987) 0.96
Immunologic characterization of cerebrospinal fluid lymphocytes: preliminary report. Neurology (1976) 0.96
The isolation and long-term culture of oligodendrocytes from newborn mouse brain. Brain Res (1984) 0.96
Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data. Acta Neurol Scand (2005) 0.96
Antigalactocerebroside serum demyelinates optic nerve in vivo. J Neurol Sci (1984) 0.96
Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J Clin Invest (1985) 0.95
Characteristics of the in vitro response of guinea pig blood lymphocytes to PHA and antigen. J Immunol (1970) 0.95
Extracellular localization of human connective tissue mast cell granule contents. J Invest Dermatol (1991) 0.95
Staphylococcal peptidoglycan: T-cell-dependent mitogen and relatively T-cell-independent polyclonal B-cell activator of human lymphocytes. Infect Immun (1983) 0.95
Aspects of lymphocyte function in myasthenia gravis. Ann N Y Acad Sci (1976) 0.95
The relationship between bronchiolitis and allergic asthma. A prospective study with allergy evaluation. J Allergy (1966) 0.94
Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann Neurol (1979) 0.93
A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barré syndrome. J Neurol Sci (1979) 0.93
Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol (1998) 0.92
Release of tryptase together with histamine during the immediate cutaneous response to allergen. J Allergy Clin Immunol (1987) 0.91
Mycobacterial suppression of delayed hypersensitivity in experimental allergic encephalomyelitis. Proc Soc Exp Biol Med (1968) 0.91
In vitro and in vivo immune responses to homologous myelin basic protein in experimental allergic encephalomyelitis. Cell Immunol (1974) 0.91
Long-term culture of oligodendrocytes isolated from rat corpus callosum by Percoll density gradient. Lysis by polyclonal antigalactocerebroside serum. J Neuropathol Exp Neurol (1983) 0.90
Serological techniques for detection of antibody to galactocerebroside. J Immunol Methods (1976) 0.90
Heterogeneity of polyclonal B-cell activity in systemic lupus erythematosus. J Clin Lab Immunol (1981) 0.89
Acute disseminated encephalomyelitis. Br J Clin Pract (1974) 0.89
Myasthenia gravis: immunological mechanisms and immunotherapy. Ann Neurol (1995) 0.89
Antiacetylcholine receptor antibody in neonatal myasthenia gravis. Am J Dis Child (1981) 0.89
Multiple sclerosis unaffected by azathioprine in pilot study. Arch Neurol (1973) 0.89
Multiple sclerosis: immunologic aspects. Ann Clin Lab Sci (1976) 0.89
Corticosteroid effects on circulating lymphocyte subset levels in normal humans. J Clin Immunol (1984) 0.88
Enrichment of Schwann cell cultures from neonatal rat sciatic nerve by differential adhesion. Brain Res (1981) 0.88
The effect of the scorbutic state on tuberculin hypersensitivity in the guinea pig. I. Passive transfer of tuberculin hypersensitivity. J Immunol (1966) 0.88
Antibodies to encephalitogenic basic protein in experimental allergic encephalomyelitis. Proc Soc Exp Biol Med (1969) 0.88
(University of Pennsylvania Case Conference): oligoclonal immunoglobulins in cerebrospinal fluid in multiple sclerosis. Clin Chem (1980) 0.88
Long-term growth in vitro of human cerebrospinal fluid T lymphocytes. J Clin Immunol (1981) 0.88